Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Cetuximab resistant NSCLC and CRC cells maintain ERK 1/2 signaling and ...
Analysis of newly generated cetuximab resistant PDX models. (A) The PDX ...
Establishment and characterization of cetuximab resistant head and neck ...
Cetuximab resistant cells displayed increased ability to growth in ...
Complement activation and expression of CRP in cetuximab resistant ...
Up-regulated FoxO3a expression in cetuximab resistant RAS WT CRC. (A ...
| Molecular mechanisms contributing to Cetuximab resistance, in ...
Stress-induced Rab11a-exosomes induce AREG-mediated cetuximab ...
Cetuximab Mechanism Of Action
| The targets to overcome cetuximab resistance in HNSCC patients. EGFR ...
Biomarkers of cetuximab resistance in patients with head and neck ...
Cetuximab-resistant RKO cell supernatant induced cetuximab resistance ...
Establishment of colorectal cells resistant to cetuximab. Human ...
The effect of LINCOO973 on cetuximab resistance. (A) Four cell lines ...
PRSS1 causes to cetuximab resistance by cleaving it and decreasing its ...
UCA1 promotes cetuximab resistance in vitro and in vivo. (A) UCA1 ...
Overcoming cetuximab resistance in SC and CC-CR cells by multi-RTK ...
Comprehensive Molecular Landscape of Cetuximab Resistance in Head and ...
Radiation resistance after treatment with cetuximab is associated with ...
Figure 1 from Mechanisms underlying resistance to cetuximab in the ...
Cetuximab Sensitivity Associated with Oxaliplatin Resistance in ...
Mechanism of cetuximab resistance in SC. (A) KEGG analysis of gene ...
Cancers | Free Full-Text | Overcoming Intrinsic and Acquired Cetuximab ...
Epacadostat Overcomes Cetuximab Resistance in Colorectal Cancer by ...
(PDF) PRSS contributes to cetuximab resistance in colorectal cancer
Cetuximab resistance models and analysis of mutation loads in 21 ...
Model of acquired resistance to cetuximab and therapeutic strategies to ...
CRART16 promotes cetuximab resistance and contributes to the ...
Stress‐induced Rab11a‐exosomes induce amphiregulin‐mediated cetuximab ...
Figure 4 from Overcoming cetuximab resistance in Ewing's sarcoma by ...
Genetic alterations predicting acquired resistance to cetuximab ...
Cetuximab retreatment in patients with treatment-resistant colorectal ...
| Molecular mechanisms contributing to Cetuximab resistance through the ...
Cell line models of acquired cetuximab resistance exhibit increased ...
(PDF) The anti-HER3 antibody patritumab abrogates cetuximab resistance ...
Figure 1 from Overcoming cetuximab resistance in Ewing's sarcoma by ...
Single‐cell sequencing analysis reveals cetuximab resistance mechanism ...
BET inhibition overcomes receptor tyrosine kinase-mediated cetuximab ...
Both ERBB2 amplification and heregulin cause cetuximab resistance in ...
Signaling pathways involved in the MLH1‐mediated cetuximab resistance ...
CAF-induced cetuximab resistance is dependent on the MMPs. A, the MMP-1 ...
Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 ...
Figure 3 from Overcoming cetuximab resistance in Ewing's sarcoma by ...
Inducing cetuximab resistance in CC cells by addition of RTK ligands ...
Overcoming de novo and acquired mode of cetuximab resistance in CRC by ...
Figure 2 from Overcoming cetuximab resistance in Ewing's sarcoma by ...
AXL mediates resistance to cetuximab therapy - PMC
Combination of copanlisib with cetuximab improves tumor response in ...
Schematic diagram of the mechanism of CRART16 in cetuximab resistance ...
3-Bromopyruvate overcomes cetuximab resistance in human colorectal ...
Heregulin causes resistance to cetuximab | Download Scientific Diagram
MIR100HG drives cetuximab resistance and metastasis in CRC cells. a ...
The Roles of RAC1 and RAC1B in Colorectal Cancer and Their Potential ...
Establishment of head and neck squamous cell carcinoma mouse models for ...
Mechanisms of resistance to EGFR antibodies.a | One mechanism of ...
Cetuximab-Induced MET Activation Acts as a Novel Resistance Mechanism ...
Cetuximab-resistant cell lines have heterogeneity A NCI-H508 cells ...
Dual kinase inhibition of EGFR and HER2 overcomes resistance to ...
Cetuximab-resistant cells harbor a missense mutation (S492R) within the ...
ARID1A mutant-like signature enriches for cetuximab-resistant patients ...
Levels of UCA1 in cetuximab-resistant and cetuximab-sensitive cells and ...
Cetuximab-resistant cell lines are sensitive to the eGFR targeted TKI ...
(PDF) Molecular Basis for Necitumumab Inhibition of EGFR Variants ...
Second-generation EGFR-TKI is effective in cetuximab-resistant FaDuCR ...
Nuclear epidermal growth factor receptor (EGFR) in cetuximab-resistant ...
Inhibition of cMET activity does not resensitize cetuximab-resistant ...
Carfilzomib Promotes the Unfolded Protein Response and Apoptosis in ...
Cetuximab-acquired-resistant cells display greater in vivo growth. (A ...
Cetuximab-resistant OSCC cells have increased NF-κB expression ...
Cetuximab: A Revolutionary Drug in Cancer Therapy - Assay Genie
Identification of cetuximab-resistant RKO cell-derived exosomes. A, RKO ...
Figure 1 from Molecular Basis for Necitumumab Inhibition of EGFR ...
Exosomes derived from cetuximab-resistant cells conferred drug ...
TKIs retain capacity to inhibit HER signaling in cetuximab-resistant ...
Cetuximab-resistant (CtxR) clones have increased HER family receptor ...
Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes ...
Systems analysis identifies potential target genes to overcome ...
The analysis of the circRNAs in the progress of acquired resistance to ...
Figure 2 from Molecular Basis for Necitumumab Inhibition of EGFR ...
Combinatorial treatment delays the emergence of acquired resistance in ...
JCI Insight - Rational combination with PDK1 inhibition overcomes ...
Experimental and Therapeutic Medicine
Effects of resveratrol in cetuximab-resistant cells in vivo. (A) The ...
Selective inhibition of PI3K110α as a novel therapeutic strategy for ...
Hypothesis for the overcoming of acquired resistance to cetuximab. The ...